Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Burns A, Rasmussen M, Andersson NW, Quinn L; DBDS Genomic Consortium; Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H; Estonian Biobank Research Team; FinnGen; Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B.
Geller F, et al. Among authors: feldt rasmussen u.
Nat Genet. 2026 Jan 22. doi: 10.1038/s41588-025-02484-9. Online ahead of print.
Nat Genet. 2026.
PMID: 41571831